KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Synopsys (SNPS) EBT (2016 - 2025)

Historic EBT for Synopsys (SNPS) over the last 17 years, with Q4 2025 value amounting to $516.5 million.

  • Synopsys' EBT rose 5997.45% to $516.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.4 billion, marking a year-over-year decrease of 797.41%. This contributed to the annual value of $1.4 billion for FY2025, which is 797.41% down from last year.
  • Latest data reveals that Synopsys reported EBT of $516.5 million as of Q4 2025, which was up 5997.45% from $189.3 million recorded in Q3 2025.
  • In the past 5 years, Synopsys' EBT ranged from a high of $516.5 million in Q4 2025 and a low of $177.1 million during Q1 2021
  • In the last 5 years, Synopsys' EBT had a median value of $309.7 million in 2023 and averaged $306.1 million.
  • As far as peak fluctuations go, Synopsys' EBT skyrocketed by 10181.49% in 2023, and later tumbled by 5170.6% in 2025.
  • Synopsys' EBT (Quarter) stood at $199.1 million in 2021, then increased by 0.5% to $200.1 million in 2022, then soared by 101.81% to $403.8 million in 2023, then fell by 20.03% to $322.9 million in 2024, then surged by 59.97% to $516.5 million in 2025.
  • Its last three reported values are $516.5 million in Q4 2025, $189.3 million for Q3 2025, and $396.2 million during Q2 2025.